Ayurcann Holdings Corp. (CSE:AYUR)

Canada · Delayed Price · Currency is CAD

0.0050

0.00 (0.00%)

At close: Feb 27, 2026

Revenue by Segment

Financials in millions CAD. Fiscal year is July - June.

Millions CAD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019
Pharmaceuticals	31.11M	25.16M	12.49M	9.39M	7.63M
Pharmaceuticals Growth	23.66%	101.39%	33.09%	22.96%	1147.68%
Total	31.11M	25.16M	12.49M	9.39M	7.63M
Total Growth	23.66%	101.39%	33.09%	22.96%	1147.68%

Revenue by Geography

Financials in millions CAD. Fiscal year is July - June.

Millions CAD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019
Canada	31.11M	25.16M	12.49M	9.39M	7.63M
Canada Growth	23.66%	101.39%	33.09%	22.96%	1147.68%
Total	31.11M	25.16M	12.49M	9.39M	7.63M
Total Growth	23.66%	101.39%	33.09%	22.96%	1147.68%

Source: S&P Global Market Intelligence.